DC cell immunotherapy, is by Quanzhou Fengze Ruijin Hospital Liver Disease Treatment Center famous liver disease scientific research group of experts after several years of scientific and technological research, put into the research and development, standardization and practical application of the latest scientific research and technological achievements of liver disease in the clinic, the authoritative experts in the field of liver disease of Quanzhou Fengze Ruijin Hospital Liver Disease Treatment Center in the eastern region of the first to introduce, to promote the new treatment of liver disease technology has given a high degree of evaluation.
It is understood that "DC cellular immunotherapy" as the international cutting-edge bio-immunity technology, in the treatment of viral infections and other diseases has achieved remarkable efficacy. With the "DC cell immunotherapy" in the domestic clinical application of the breakthrough progress, showing the technology in the treatment of liver disease, cirrhosis and liver fibrosis unique advantages. According to the introduction, this kind of body therapy is to collect mononuclear cells from the human body, carry on the special culture in vitro, become the immunity cell which specializes in killing the virus of liver disease, and then precisely aim at and kill the virus of liver disease after infusing into the human body, and there is no damage to the normal liver cells. The use of patients' own cells to treat their own diseases, liver treatment technology, with the virus gene mutation detection, biochip efficacy assessment of the two high-tech technology together, constituting the detection, treatment, assessment of the trinity of the new liver disease treatment mode, completely rid of the traditional mode of drug treatment of liver disease, from the root to break the long plagued by the clinical immune tolerance problem.